The office-to-residential conversion of Pfizer’s former New York headquarters remains on track for completion by the end of next year despite the structural issues that triggered evacuations and halted activity around the site this week, according to lead developer MetroLoft.
MetroLoft: New York Pfizer building conversion won’t be delayed by structural issues
Developer says damage from buckled columns is limited to fewer than 30 apartments
By Andria Cheng
CoStar NewsJuly 9, 2026 | 12:27 AM
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- Metro Loft Management
Real Estate
- David Werner Real Estate Investments
Real Estate